Randox Laboratories has released a Biochip analyser for onsite drug testing.
This development brings the Biochip Array Technology to the point-of-care market, offering a higher level of information than ever achieved from a rapid drug screen, according to the company.
The Evidence Multistat analyser is a fully automated bench-top system with a touchscreen interface.
Users can detect up to 97 drug metabolites in one patient sample in as little as 20min.
The procedure offers efficient testing that can be carried out with minimal training.
The Evidence Multistat analyser utilises Biochip Array Technology, a multiplexing methodology.
Another feature of the analyser is its ability to automatically generate quality-control data, ensuring optimum performance and reliable results.
Primarily, the Evidence Multistat has been adopted in hospital emergency departments, with Biochip Array Technology ensuring fast and accurate results, leading to better patient treatment.
In addition, the Randox range of Evidence biochip analysers offers a comprehensive test menu for toxicology screening and pain management.